NCT01143337View on ClinicalTrials.gov

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MP-435(dose1) + Methotrexate

MP-435 dose1 + stable weekly dose of Methotrexate

DRUG

Placebo + Methotrexate

Placebo + stable weekly dose of Methotrexate

Trial Locations (1)

Unknown

Investigational site, Osaka

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY